BMO Capital upgraded Omega Healthcare (OHI) to Outperform from Market Perform with an unchanged price target of $45. The firm expects continued “robust” accretive acquisitions from Omega with its estimates modestly above the Street. The company has a strong balance sheet to drive earnings while its diversified tenant base “limits idiosyncratic credit risk,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $37 from $35 at Mizuho
- Omega Healthcare price target raised to $43 from $39 at BofA
- Omega Healthcare price target raised to $43 from $39 at RBC Capital
- Omega Healthcare Investors Shows Strong Q3 Performance
- Omega Healthcare upgraded to Outperform from Neutral at Exane BNP Paribas